New nano approach could cut dose of leading HIV treatment in half

From an article at
Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, a leading annual conference of HIV research, clinical practice and progress.
The healthy volunteer trial, conducted by the collaborative nanomedicine research programme led by Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, and in collaboration with the St Stephen’s AIDS Trust at the Chelsea & Westminster Hospital in London, examined the use of nanotechnology to improve the delivery of drugs to HIV patients. The results were from two trials which are the first to use orally dosed nanomedicine to enable HIV therapy optimisation.


[button link=”” color=”custom” size=”medium” stretch=”” type=”flat” shape=”pill” target=”_blank” title=”” gradient_colors=”|” gradient_hover_colors=”|” accent_color=”” accent_hover_color=”” bevel_color=”” border_width=”1px” icon=”” icon_divider=”yes” icon_position=”left” modal=”” animation_type=”0″ animation_direction=”down” animation_speed=”0.1″ animation_offset=”” alignment=”left” class=”” id=””]Read more at [/button]timthumb.php_
Image Credit:  University of Liverpool

[title size=”2″ content_align=”left” style_type=”single solid” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””]Recent News[/title][recent_posts layout=”default” hover_type=”zoomin” columns=”3″ number_posts=”120″ offset=”” cat_slug=”News” exclude_cats=”” thumbnail=”yes” title=”yes” meta=”yes” excerpt=”yes” excerpt_length=”30″ strip_html=”yes” animation_type=”0″ animation_direction=”down” animation_speed=”1″ animation_offset=”” class=”” id=””][/recent_posts]


Leave A Comment